Navigation Links
New Therapies may Help to Avoid Transplant in Some Heart Failure Patients

tage heart failure between August 2001 and October 2003 in the first prospective, multicenter study to extensively examine how LVADs affect cardiac function and exercise capacity over several months.

Patients were recruited from these centers: Baylor College of Medicine, Houston, Texas; Cleveland Clinic Foundation, Ohio; Columbia University, New York City; University of Michigan, Ann Arbor; University of Minnesota, Minneapolis; Temple University, Philadelphia, Penn.; and the Texas Heart Institute, Houston. Four different types of LVADs were used in the study. Researchers evaluated the patients every 30 days after pump implant.

"There are two contrasting, important findings in our study," Maybaum said. "One, the ability to remove an LVAD from a patient with end-stage heart failure was low. Two, there was a high degree of improvement in heart function during the use of the assist device."

Six (9 percent) of the 67 patients had their pump removed without needing a heart transplant. Six others (9 percent) had died by May 2004, when data collection ended.

Yet, after 30 days on the pump, one third of the patients had a left ventricular ejection fraction greater than 40 percent (measured when the pump flow was decreased). Ejection fraction is the percentage of blood pumped out of the left ventricle with each beat. Healthy hearts typically have an ejection fraction of 55 percent to 60 percent, Maybaum said. The proportion of patients showing this degree of improvement then waned, dropping to 27 percent of patients at 60 days, 19 percent at 90 days and 6 percent at 120 days.

Patients also showed progressive improvement in exercise capacity after LVAD implantation. From day 30 to 120 there was an increase in their peak oxygen consumption and how long they could exercise.

Tiny snips of heart tissue from 22 patients taken at implant and at the time of removal of the LVAD prior to transplan
'"/>




Page: 1 2 3

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Preventive Therapies Found to be More Effective in Managing Migraines
3. Ayurvedic Therapies Cashing In On Medical Tourism
4. Immune-Boosting Therapies Of No Use In Preventing Miscarriage
5. Non Hormonal Therapies for Menopause Not Proved to be Effective
6. Need for More Talking Therapies for Treating Depression
7. Are Alternative Therapies A Reliable Alternative?
8. Special Behavioral Therapies made Women more likely to Attempt Suicide
9. Anti-Retroviral Therapies Associated with Reduced Infections in HIV-Infected Children
10. Alternative Therapies May Not Ease Menopause Symptoms
11. Emerging Therapies for Skin Cancer Treatment
Post Your Comments:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...ed by British researchers, breast fed babies have ...counterparts//. This once again goes on to prove t...y was conducted by Institute of Child Health in Lo...up of four to six. In this group, 184 children ha...
...aused by mutant prion proteins, such as mad cow di...ormal prion proteins can be depleted, researchers ...orm of mad cow disease called variant Creutzfeldt-... when prion protein in the brain becomes misfolded...
... commonly used for cosmetic procedures and to reli...tic drugs such as lidocaine, tetracaine, benzocain...m. The FDA says such products can cause serious ... as irregular heart beat, seizures and coma, and c...
...led nephrogenic systemic fibrosis (NSF)— which occ...is strongly// related to use of gadolinium dyes fo... Journal of the American Society of Nephrology. A...ecific groups of patients in whom gadolinium expos...
Other Medicine News:Health News:FDA Warns of Deadly Results of Skin-numbing Creams 2Health News:MRI Contrast Agent Linked to Complication in Renal Patients 2
(Date:8/18/2008)...life expectancy for people with,Down syndrome, WA...e world of Down,syndrome, ,Mr. C, is a rarity. A r... past 16 years, at seventy, ,Mr. C, has well surpa...Down syndrome, currently in the,late fifties, but ...C, does,not exhibit clinical symptoms of Alzheimer...
(Date:8/18/2008)... in Phase I -, PRINCETON, N.J. and SAN DIEGO, Aug...linical stage biotechnology company committed to t...eatening and life-altering,infectious diseases, to...,B2 by the U.S. Patent and Trademark Office, cover...y in Phase I development for the treatment of HIV-...
(Date:8/14/2008).../ -- AstraZeneca (NYSE: AZN ),today announced an ...r,Centre Singapore (NCCS) and the National Univers...s. The collaboration, which is spelt out in a,Memo...y, aims to further,build AstraZeneca,s drug develo... access to new medicines of potential benefit to p...
(Date:8/14/2008)...re/ -- The Clinical Trials,Bootcamp announces its ...linical coordinators, clinical research staff and ...eld in Boca Raton at the Boca Resort from May,14-1...inators, monitors and,other industry personnel wil...nical trials into a practice, as well as how to ta...
Breaking Medicine Technology:Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 2Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 2AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 5AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 6Sirion Therapeutics Highlights Pivotal Trial Results of Durezol 28TM 29 at the American Society of Cataract and Refractive Surgery Annual Symposium 4456 1Sirion Therapeutics Highlights Pivotal Trial Results of Durezol 28TM 29 at the American Society of Cataract and Refractive Surgery Annual Symposium 4456 2Sirion Therapeutics Highlights Pivotal Trial Results of Durezol 28TM 29 at the American Society of Cataract and Refractive Surgery Annual Symposium 4456 3Cow stomach holds key to turning corn into biofuel 2804 1Cow stomach holds key to turning corn into biofuel 2804 2Cow stomach holds key to turning corn into biofuel 2804 3Death protein research secures funding for UCF scientists 2802 1Death protein research secures funding for UCF scientists 2802 2Adults Need Protection Against Vaccine Preventable Diseases Too 16226 1Adults Need Protection Against Vaccine Preventable Diseases Too 16226 2
...--(BUSINESS WIRE)--Jun 26, 2007 - Acceleron Pharma...rapeutics for the,treatment of musculoskeletal, me...ed results demonstrating that ACE-011, a,novel ana...reserved,bone mass and architecture in a murine mo...ignancy of plasma cells in the bone marrow,that di...
...a.--(BUSINESS WIRE)--Jun 26, 2007 - Insmed Incorpo...ocused on the,development and approval of drugs fo...edical needs, today noted the publication of,promi...egarding the,potential role of insulin-like growth...ion of blindness among premature infants., IGFBP-3...
Other Medicine Technology:ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical,Model 2ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical,Model 3Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of,Blindness in Premature Infants 2Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of,Blindness in Premature Infants 3
1000 L, Racked, Filtered, Pre-sterilized, 100 tips/rack Recommended for 500 and 1000 L pipettes.
Inquire
Finntip Filters are ideal for PCR and other amplification methods, or for any work where aerosol contamination might occur. They are designed for pipetting DNA/RNA solutions, infectious materials, la
Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote
Medicine Products: